Sangel Capital Investor
Sangel Capital as one of the earliest globally operating professional biomedical venture capital institutions was established in China in 2010, focusing on life science and technology, and having leading professional advantages and rich project resources in the biomedical investment industry.
Sangel Capital has offices in Shenzhen, Beijing, Suzhou, and Chicago. We bring together a group of investment and advisory teams composed of industry experts, scientists, and investors in the field of life technology to manage and operate a series of RMB and USD funds.
Founded Date:
2009-01-01
Number Of Exists:
1
Industry:
Clinical AI
Headquarters:
Shenzhen,Guangdong,China,Asia
Technology:
Clinical Decision Support Systems (CDSS)
Investor Type:
Venture Funds
Employee Number:
400
Funding Status:
private